Pardes Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Provided By Globe Newswire

Last update: Mar 14, 2023

Data from ongoing Phase 2 trial evaluating pomotrelvir (formerly known as PBI-0451) for the treatment of COVID-19 expected in the coming weeks